Cross-sectional study demonstrates strong correlation between transcutaneous and total serum bilirubin in term neonates, indicating effectiveness as a screening tool.
Key Points
Transcutaneous bilirubin shows strong correlation with total serum bilirubin in newborns, enhancing screening accuracy.
Correlation coefficient of r=0.849 suggests reliable results based on data from 137 neonates in the study.
Cross-sectional observation study evaluated two measurement methods for bilirubin in term neonates to establish effectiveness.
Findings support transcutaneous bilirubin as a viable non-invasive option for hyperbilirubinemia screening in newborns.